[Asia Economy Reporter Hyunseok Yoo] Raon People announced on the 12th that Laon Sleep, an AI-based sleep apnea video detection and diagnosis software, has been designated as the 11th innovative medical device by the Ministry of Food and Drug Safety.


This software is the result of a convergence project between Raon People's AI technology, engineering technology, and medical technology from Yonsei University. It automatically extracts the shape of the airway from the patient's computed tomography (CT) images and analyzes biometric information using AI to assist in the diagnosis of sleep apnea.


Previously, a convergence research group composed of professors from Yonsei University's College of Engineering, Medical School, and Dental School obtained exclusive licenses for two patents filed domestically and in the United States, including the "Method for Diagnosing Sleep Apnea Using Machine Learning," and jointly developed the sleep apnea AI diagnostic device "Laon Sleep." With the cooperation of Yonsei Medical Center and clinical trials, they announced plans to commercialize the product after receiving approval from the Ministry of Food and Drug Safety.


The initial model based on AI sleep apnea diagnosis technology and airway shape segmentation technology has been completed and is ready for service. With this designation as an innovative medical device by the Ministry of Food and Drug Safety, it is expected that the commercialization, overseas certification, and export of products applying AI convergence medical technology will be accelerated.



A Raon People official stated, "Since patent applications have been completed not only in Korea but also in the United States and globally, along with the designation as an innovative medical device by the Ministry of Food and Drug Safety, we expect to quickly establish ourselves as an innovative sleep apnea AI diagnostic solution in the global market."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing